Man Boobs and ED: Causes, Tests and Treatment

Man boobs, or gynaecomastia, and erectile dysfunction (ED) are two conditions that can share the same underlying causes, raising the question of whether one might signal the other. Both are linked to hormonal imbalances, particularly low testosterone and elevated oestrogen, as well as obesity, certain medications and systemic illnesses. Understanding the connection between gynaecomastia and ED can help men recognise when symptoms together warrant medical attention, what investigations are available on the NHS, and what lifestyle changes may improve both conditions at the same time.

What causes man boobs and could they be linked to ED?

Gynaecomastia and ED can share underlying causes, including low testosterone, obesity, liver disease and certain medications, meaning both conditions may reflect the same hormonal or systemic problem rather than one causing the other.

Gynaecomastia (enlarged breast tissue in men) and erectile dysfunction (ED) can share common underlying causes, meaning that having one condition may sometimes point towards the other, though neither automatically causes the other. Gynaecomastia occurs when glandular breast tissue grows in response to a hormonal imbalance, most commonly a relative excess of oestrogen compared to testosterone.^[3][4] ED, defined as the persistent difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity, can also arise from hormonal, vascular, neurological or psychological factors.^[1][15]

Both conditions become more common with age, and both can be triggered by the same root causes, including low testosterone (hypogonadism), obesity, certain medications, liver disease, kidney disease and thyroid disorders. Some medicines are particularly associated with both problems, including:

• Spironolactone (used for heart failure and high blood pressure)

• Cimetidine (an older antacid)

• Some antipsychotics and antidepressants, including risperidone and amisulpride, which can raise prolactin levels

• Anabolic steroids, which paradoxically suppress natural testosterone production

• Finasteride and dutasteride (used for prostate conditions and hair loss)

• Anti-androgens such as bicalutamide, certain opioids, ketoconazole and some antiretrovirals

If you think a prescribed medicine may be contributing to your symptoms, do not stop taking it without speaking to your GP, pharmacist or specialist first. Any decision to switch or stop a medicine must be clinician-led, as stopping abruptly can be harmful. If you experience unexpected symptoms that you suspect may be related to a medicine, you can report them to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk.

It is important to note that pseudogynaecomastia, which is fatty tissue rather than true glandular growth, is common in men who carry excess weight and does not carry the same hormonal significance. True gynaecomastia, however, warrants investigation because it may reflect a hormonal or systemic condition that also affects sexual function. If you have noticed breast tissue enlargement alongside changes in erections, libido or energy levels, these symptoms together are worth discussing with a GP rather than dismissing either in isolation.

How hormonal imbalances connect gynaecomastia and erectile dysfunction

Low testosterone is the most direct hormonal link, as falling levels shift the oestrogen-to-testosterone ratio, driving breast tissue growth and impairing erectile function simultaneously. Elevated prolactin and obesity-related aromatisation are also important shared mechanisms.

Low testosterone is the most direct hormonal link between gynaecomastia and erectile dysfunction, because testosterone plays a central role in both maintaining normal breast tissue composition and supporting erectile function. When testosterone levels fall, the ratio of oestrogen to testosterone shifts, stimulating breast glandular tissue to grow while simultaneously reducing libido, energy and the ability to achieve erections. This condition, known as hypogonadism, can be primary (originating in the testes) or secondary (originating in the pituitary gland or hypothalamus).

In UK practice, testosterone is measured as a total testosterone sample taken in the early morning, ideally between 08:00 and 11:00, when levels are at their highest.^[14] If the result is low or borderline, the test is repeated to confirm the finding. Sex hormone-binding globulin (SHBG) is also measured when indicated, because it affects how much testosterone is biologically available; calculated free testosterone is used rather than a direct free testosterone measurement in most UK laboratories.^[14]

Elevated prolactin, a hormone produced by the pituitary gland, is another important shared mechanism. Hyperprolactinaemia suppresses the release of luteinising hormone (LH) and follicle-stimulating hormone (FSH), which in turn reduces testosterone production.^[6][7] The result can be both gynaecomastia and ED occurring together, sometimes accompanied by reduced facial hair, fatigue and mood changes. Before arranging pituitary imaging, clinicians will typically exclude macroprolactin (a common laboratory artefact), physiological causes and drug-induced causes. Persistent, markedly raised prolactin that is not explained by these factors warrants MRI of the pituitary gland to exclude a pituitary adenoma (a benign tumour).

Oestrogen excess from other sources also matters. Obesity increases the conversion of androgens to oestrogens in fatty tissue through a process called peripheral aromatisation.^[3][7] This means that men with a higher body mass index (BMI) are at greater risk of both conditions simultaneously, not simply because of weight itself but because of the hormonal environment that excess adipose tissue creates. Liver disease impairs oestrogen metabolism, further compounding this effect.

Understanding the hormonal pathway is clinically useful because treating the underlying imbalance, rather than each symptom separately, often improves both conditions at once. This is why blood tests to assess hormone levels are a logical first step when both gynaecomastia and ED are present.

Should I see a GP if I have both gynaecomastia and erection problems?

Yes, see a GP if you have both conditions, especially if symptoms are new or worsening, as the combination may indicate an underlying hormonal or systemic cause. Urgent assessment is needed for a hard breast lump, nipple discharge or new testicular swelling.

Yes, you should see a GP if you have both gynaecomastia and erection problems, particularly if either symptom is new, worsening or accompanied by other changes such as fatigue, reduced body hair, testicular pain or changes in mood. While both conditions are common individually and are often benign, their combination raises the possibility of an underlying hormonal or systemic cause that benefits from investigation and, where found, treatment.

You should contact your GP promptly (rather than waiting) if you notice:

• Breast tissue that is tender, hard, rapidly enlarging or associated with nipple discharge, as this warrants prompt examination. A unilateral hard breast mass or nipple discharge in a man should be assessed urgently, in line with NICE guidance on suspected cancer (NICE NG12), to exclude male breast cancer.^[13]

• A new testicular lump or swelling, which also requires urgent assessment to exclude testicular cancer, in line with NICE NG12.

• Erection problems that have developed suddenly, which can occasionally signal cardiovascular disease. If ED is accompanied by chest pain, shortness of breath or other acute cardiac symptoms, seek same-day urgent medical help.

• Symptoms of low testosterone such as significant fatigue, low mood, reduced muscle mass or hot flushes alongside either condition.

NICE clinical knowledge summaries (CKS) on erectile dysfunction advise that men presenting with ED are assessed for cardiovascular risk factors, diabetes and lipid levels, because ED can be an early marker of endothelial dysfunction and arterial disease. This makes a GP consultation important not only for quality of life but potentially for longer-term health.

For men who prefer to begin with an online consultation, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support. Mounjaro and other prescription treatments are options a prescriber may consider after an online consultation with Bolt Pharmacy, and are only prescribed where clinically appropriate. A face-to-face GP appointment remains the appropriate route when physical examination or blood tests are needed. Regardless of where you start, do not delay seeking advice if symptoms are affecting your wellbeing or if you are concerned about an underlying cause.

What tests and treatments are available on the NHS?

NHS investigation includes early-morning testosterone, LH, FSH, prolactin, oestradiol, thyroid and liver function tests, with MRI of the pituitary if indicated. Treatment depends on the cause, with generic sildenafil available for ED and testosterone replacement considered for confirmed hypogonadism.

NHS investigation of gynaecomastia and ED typically begins with a clinical history and examination, followed by targeted blood tests to identify any underlying cause. A GP will usually request:

• Total testosterone, sampled in the early morning (08:00 to 11:00) and repeated if low or borderline, with SHBG measured when indicated to allow calculation of free testosterone

• LH and FSH, to assess the hypothalamic-pituitary-gonadal axis

• Prolactin, to identify hyperprolactinaemia

• Oestradiol, if oestrogen excess is suspected

• Thyroid function tests (TFTs), as both hypothyroidism and hyperthyroidism can cause gynaecomastia

• Liver function tests and renal function, to exclude hepatic or renal causes

• Fasting glucose and lipid profile, given the association with metabolic syndrome

If a pituitary cause is suspected after excluding macroprolactin and drug or physiological causes, an MRI of the pituitary gland may be arranged. Testicular ultrasound can be requested if a testicular tumour is a concern, as these can secrete hormones that cause gynaecomastia.

Treatment on the NHS depends on the underlying cause. Where hypogonadism is confirmed, testosterone replacement therapy (TRT) may be considered, though this requires specialist input and monitoring. If a medicine is identified as the cause, switching to an alternative where clinically safe is often the first step, and this decision must always be made by a clinician.

For ED, generic sildenafil is generally available on NHS prescription. Other PDE5 inhibitors (such as tadalafil, vardenafil and avanafil) may be subject to the NHS Selected List Scheme (SLS), which means they are only reimbursable on the NHS when specific clinical criteria are met or when initiated by a specialist; local ICB policies also apply.^[14] NICE CKS on erectile dysfunction supports the use of PDE5 inhibitors as first-line treatment for ED in appropriate patients.^[14][19] If you are unsure what is available to you, your GP or pharmacist can advise on current NHS arrangements in your area.

Surgical correction of gynaecomastia (subcutaneous mastectomy) is available on the NHS in some cases but is generally considered only when the condition is longstanding, causing significant psychological distress, and has not responded to treatment of the underlying cause. Local ICB commissioning policies vary, so eligibility differs by area.

Can lifestyle changes improve both conditions at the same time?

Yes, weight reduction, aerobic exercise, reducing alcohol and treating obstructive sleep apnoea can improve both conditions by raising testosterone, reducing oestrogen excess and supporting vascular health. Lifestyle changes work best alongside medical investigation, not as a substitute.

Lifestyle changes can meaningfully improve both gynaecomastia and erectile dysfunction at the same time, particularly when excess weight, physical inactivity, alcohol use or poor sleep are contributing factors. Because obesity drives peripheral aromatisation (the conversion of androgens to oestrogens in fatty tissue) and impairs vascular function, weight reduction addresses two of the most common mechanisms underlying both conditions simultaneously.

Evidence consistently supports the following approaches:

• Weight management: Reducing BMI through a sustainable calorie deficit and increased physical activity can raise testosterone levels, reduce oestrogen excess and improve endothelial function, all of which benefit both conditions. Even a modest reduction in body weight can produce measurable hormonal and erectile improvements, as supported by NHS and NICE guidance on obesity and ED management.

• Aerobic and resistance exercise: Both forms of exercise support cardiovascular health (relevant to ED) and help preserve lean muscle mass, which is associated with healthier testosterone levels.

• Reducing alcohol intake: Alcohol impairs liver metabolism of oestrogens and can directly suppress testosterone production. The UK Chief Medical Officers' Low Risk Drinking Guidelines advise keeping consumption to no more than 14 units per week, spread across several days, with some alcohol-free days.^[16]

• Stopping anabolic steroids or performance-enhancing drugs: These are a significant and underreported cause of both conditions in men who use them for bodybuilding, and cessation is the most important intervention in this group.

• Improving sleep: Poor sleep, particularly obstructive sleep apnoea (OSA), is associated with reduced testosterone and worsened ED.^[20][21] If you experience loud snoring, witnessed pauses in breathing or excessive daytime sleepiness, speak to your GP about assessment for OSA, as treating it can support hormonal recovery.

Lifestyle changes work best alongside medical investigation rather than as a substitute for it. If symptoms persist despite meaningful lifestyle improvement, returning to your GP for further assessment is the appropriate next step.

Scientific References

1. Erectile dysfunction (impotence).
2. Anabolic steroid misuse.
3. Drug-induced gynecomastia.
4. Estrogens and the human male.
5. Health consequences of anabolic steroids: a sexual-medicine perspective.
6. Idiopathic hyperprolactinemia-associated hypogonadism in men presenting with normal testosterone levels.
7. Male Reproductive Endocrine Disorders.
8. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
9. A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome.
10. Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.
11. Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review.
12. A mourning case that referred with sexual identity disorder secondary to a general medical condition [spironolactone and gynaecomastia/ED].
13. Suspected cancer: recognition and referral (NG12).
14. Clinical Knowledge Summary: Erectile Dysfunction.
15. CIALIS (tadalafil) – EMA Product Information.
16. Alcohol consumption: advice on low risk drinking.
17. Erectile dysfunction and cardiovascular health.
18. Erectile dysfunction, type 2 diabetes, and cardiovascular disease: a narrative review.
19. The impact of PDE5 inhibitors on cardiovascular outcomes.
20. Sleep disorders and male sexual dysfunction: a meta-analysis of hormonal and erectile outcomes.
21. The impact of obesity and obstructive sleep apnea on vascular hemodynamics in men under 40.
22. Easy blood oxygen accumulation distribution area index (EBOADAI): association with testosterone deficiency and sexual health in adult males.

Frequently Asked Questions